SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 102.11 |
| Enterprise Value ($M) | 107.31 |
| Book Value ($M) | 20.07 |
| Book Value / Share | 1.17 |
| Price / Book | 5.09 |
| NCAV ($M) | -11.99 |
| NCAV / Share | -0.70 |
| Price / NCAV | -8.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.32 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -1.13 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.96 |
| Current Ratio | 1.37 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 48.18 |
| Assets | 80.24 |
| Liabilities | 60.17 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 56.13 |
| Operating Income | -13.68 |
| Net Income | -14.67 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -9.13 |
| Cash from Investing | -15.00 |
| Cash from Financing | 16.99 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Tang Capital Management Llc | 7.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 13,216 | 81,144 | 16.29 | |
| 6,183 | 37,852 | 16.33 | |
| 16,660 | 60,047 | 27.74 | |
| 9,733 | 46,840 | 20.78 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CYCN – Cyclerion Therapeutics, Inc. | CYRX – Cryoport, Inc. |
| DARE – Daré Bioscience, Inc. | DMAC – DiaMedica Therapeutics Inc. |
| DNTH – Dianthus Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io